UNICYCIVE THERAPEUTICS, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- UNICYCIVE THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2026-06-30 was $14.44M, a 51.38% increase year-over-year.
- UNICYCIVE THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2026-03-31 was $19.57M, a 622.90% increase year-over-year.
- UNICYCIVE THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2025-09-30 was $26.33M.
- UNICYCIVE THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2025-06-30 was $9.54M.
- UNICYCIVE THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2025 was $45.18M, a 8522.90% increase from fiscal 2024.
- UNICYCIVE THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2024 was $524.00K.
- UNICYCIVE THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2022 was $11.00K.
- UNICYCIVE THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2020 was $142.00K.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $14.44M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $19.57M 10-Q · filed 2026-08-12 | |
| 2025-12-31 | $45.18M 10-K · filed 2026-03-30 | |
| 2025-09-30 | $26.33M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $9.54M 10-Q · filed 2026-08-12 | |
| 2025-03-31 | $2.71M 10-Q · filed 2026-08-12 | |
| 2024-12-31 | $524.00K 10-K · filed 2026-03-30 | |
| 2022-12-31 | $11.00K 10-K · filed 2024-03-28 | |
| 2021-09-30 | $22.27M 10-Q · filed 2022-11-14 | |
| 2020-12-31 | $142.00K 10-K · filed 2022-03-31 | |
| 2020-06-30 | $92.00K 10-Q · filed 2021-11-12 | |
| 2020-03-31 | $50.00K 10-Q · filed 2021-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |